Medipost Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medipost Co Ltd with three other
companies in this sector in South Korea:
Legochem Biosciences Inc
sales of 16.66 billion Korean Won [US$14.81 million]
(22.21 billion Korean Won [US$19.74 million]
of which 52%
was Biotechnology), and
(21.70 billion Korean Won [US$19.29 million]
Medipost Co Ltd reported sales of 28.65 billion Korean Won (US$25.47 million)
December of 2016.
decrease of 23.7%
versus 2015, when the company's sales were 37.57 billion Korean Won.
Contributing to the drop in overall sales was the 33.7% decline
in Umbilical Cord Blood, from 23.97 billion Korean Won to 15.88 billion Korean Won.
However, these declines were partially offset by the increase in sales of
Therapy Sales (up 36.7% to 5.64 billion Korean Won)
Health Food (up 1.2% to 4.25 billion Korean Won)
Other Segments (up 5.0% to 2.88 billion Korean Won)